AGP Executive Report
Last update: 3 hours agoHepatitis B Vaccine Study: The U.S. CDC is moving to allocate $1.6 million for a previously suspended clinical trial in Guinea-Bissau examining the hepatitis B vaccine birth dose. The study’s revised protocol followed an international ethics controversy, and the funding is drawn from the agency’s global health security budget. Regional Disease Surveillance: West African veterinary and public health officials met in Lomé from October 6 to 8 to strengthen early detection and control of animal diseases that can cross borders. The ECOWAS gathering also reviewed regional disease risks and ways to improve coordination among veterinary services and surveillance networks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
